C-reactive protein in heart failure: prognostic value and the effect of valsartan.

MLA

Anand IS, et al. “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan.” Circulation, vol. 112, no. 10, Sept. 2005, pp. 1428–34. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106144709&authtype=sso&custid=ns315887.

APA

Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R, Cohn JN, & Val-HeFT Investigators. (2005). C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation, 112(10), 1428–1434.

Chicago

Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, et al. 2005. “C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan.” Circulation 112 (10): 1428–34. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106144709&authtype=sso&custid=ns315887.